Both CXCL9/MIG and CXCL10/IP-10 are chemotactic for stimulated CXCR3-expressing T lymphocytes that could further amplify IFN-γ at the tumour site (Farber, 1997). This evidence concerns the gene CXCR3 and neoplasm.